Solid_Bio
Rare Disease Therapeutics · Cell & Gene Therapy
Facts
as of Nov 17, 2026Focused on advancing genetic medicines for neuromuscular and cardiac diseases. We are focused on advancing genetic medicines for rare neuromuscular and cardiac diseases.
- Employees
- 501-1000estimated range
- Website
- solidbio.com
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Newsroom
top 2%Web presenceof 133.2M domains by links, Common Crawl
Jun 252026
Blog
Dear Duchenne Community, As we come together for the annual Parent Project Muscular Dystrophy (PPMD) conference over the next several days, we want to begin by recognizing the st…
Jan 122026
Blog
Dear Friedreich's ataxia (FA) community, As we begin the new year, we want to wish you and your families a happy and healthy 2026 and thank the FA community for your trust and pa…
Jul 8, 20252025
Blog
Dear CPVT Community, We are pleased to introduce Solid Biosciences to the CPVT community-and to share important news about our investigational gene therapy, SGT-501. Patient-focu…
Feb 18, 20252025
Blog
Letter to the Duchenne Community: With heartfelt gratitude, I want to begin by thanking the patients and families participating in the INSPIRE DUCHENNE clinical study - you are t…
Nov 7, 20242024
Blog
Dear Duchenne Community, Earlier today we reported third quarter financial results and provided updates on Solid Biociences Inc.' ("Solid") business. Among the highlights, we sha…
Aug 14, 20242024
Blog
Dear Duchenne Community, We are writing to share an important update on INSPIRE DUCHENNE, our Phase 1/2 clinical trial of SGT-003 for the treatment of patients living with Duchen…
Sources: the outlets named on each headline, each story once
